ACCIDENTS DES
VACCINS CONTRE
L’HÉPATITE B DANS LA
LITTERATURE MEDICALE
ACCIDENTS
LOCAUX (AU POINT
D’INJECTION)
Granulome par
sensibilisation à
l’aluminium
COSNES A,
FLECHET ML, REVUZ.
Inflammatory nodular reaction after hepatitis B vaccination due
to aluminium sensitization. Contact Dermatitis 1990;23
:65-67
HUTTEROTH TH, QUAST U.
Aluminiumhydroxid-granulome nach hepatitis-B impfung. Deutsch
Med Wochensch. 1990,
115(12):476
SKOWRON F, GREZARD P, BERARD F, BALME B, PERROT
H.
Persistent nodules at sites of hepatitis B vaccination due to
aluminium sensitization. Contact Dermatitis.
1998;39(3):135-136
AJITHKUMAR K, ANAND U, PULIMOOD S, CHANDI SM, GEORGE S, JACOB
CK, THOMAS PP.
Vaccine-induced necrobiotic granuloma. Clin Exp
Dermatol.
1998 ;23(5):222-224.
Mastocytose
POULTON JK.
Solitary mastocytoma arising at a hepatitis B vaccination
site. Cutis.
1999;63(1):37-40
Nodules
inflammatoires par sensibilisation au
Thiomersal
NOEL I,
GALLOWAY A, IVE FA. Hypersensitivity to thiomersal
in hepatitis B vaccine. Lancet
1991;338:705
RIETSCHEL RL, ADAMS
RM. Reactions to thimerosal in hepatitis B vaccine.
Dermatol. Chrs.
1990;8:161-164
Zona en regard du
point d’injection
NUTINI MT.
Pharmacovigilance Hevac B Pasteur J.Am.Med.Assoc. (suppl.
hors série) 1987 :5-7
Urticaires et rashs
éruptifs
GOLDWATER
PN.
Hypersensitivity to intradermal hepatitis B vaccine. Lancet
1984;17:1156
DE SILVA L, ROGERS
M. Hepatitis B vaccine: urticarial reaction. Med.J.Austr.
1985;143:323-324
TOSTI A, MELION M,
BARDAZZI F. systemic reactions due to thimerosal. Contact
Dermatitis.
1986;15:187-188
PIERCHALLA P, PETRI
H, RUPING K. Urticaria after HB-Vax injection due to
hypersensitivity to thiomersal (merthiolate).
Allergologie 1987;10:97-99
LOHIYA G. Asthma
and urticaria after hepatitis B vaccination. The Western
J. Med. 1987;147:341
NUTINI
MT. Pharmacovigilance
Hévac B Pasteur J.Am.Med.Assoc. (suppl. hors série)
1987 :5-7
BRIGHTMAN CAJ,
SCADDING GK, DUMBRECK IA, ATCHMAN Y, BROSTOFF J.
Yeast-derived hepatitis B vaccine and yeast sensitivity.
Lancet 1989;333:903
ANDRÉ FE. Overview
of a 5-year clinical experience with a yeast-derived
hepatitis B vaccine. Vaccine
1990;8:74-78
Mc MAHON BJ,
HELMINIAK C, WAINWRIGHT RB, BULKOW L, TRIMBLE BA,
WAINWRIGHT K. Frequency of adverse reactions to hepatitis
B vaccine in 43618 persons. Am.J.Med.
1992;92:254-256
HUDSON TJ, NEWKIRK M, GERVAIS F, SHUSTER J. Adverse reaction to
the recombinant hepatitis B vaccine. J.Allergy Clin.
Immunol.1991;88:821-822 (avec erratum dans J.Allergy
Clin.
Immunol.
1993 ;92 :498)
NAGAFUCHI S,
TOKIYAMA K, KASHIWAGI S, YAYASHI S, IMAYAMA S, NIHO Y.
Eosinophilia after intradermal hepatitis B vaccination.
Lancet 1993;342: 995.
FROEHLICH H, VERMA
R.
Arthus reaction to
recombinant hepatitis B virus
vaccine. Clin Infect
Dis. 2001 Sep 15;33(6):906-8.
BECKER BA. A severe
allergic reaction presenting as an asthma exacerbation
with respiratory failure following Hepatitis B
vaccination. Journal of Allergy and Clinical Immunology.
2002 Jan; 109(1) Part Two
Oedème de Quincke
et choc
anaphylactique
NUTINI
MT.
Pharmacovigilance Hévac B Pasteur. J.Am. Med. Assoc.
(supplément hors série) 1987:
5-7
LEAR JT, ENGLISH
JSC. Anaphylaxis after hepatitis B vaccination. Lancet
1993; 345: 1249
BARBAUD A, TRECHOT P, REICHERT-PENETRAT S,
WEBER M, SCHMUTZ JL
Allergic mechanisms
and urticaria/angioedema after hepatitis B
immunization. Br J
Dermatol. 1998
Nov;139(5):925-6
ARKACCHAISRI
T.
Serum sickness and
hepatitis B vaccine including review of the
literature. J Med Assoc
Thai. 2002 Aug;85 Suppl
2:S607-12.
SAVI E, MAFFINI I, BURASTERO
SE.
A latex-containing
hepatitis-B vaccine administered in a severely latex
allergic paediatric patient after specific sublingual
immunotherapy: a case
report. Allergy. 2004
Sep;59(9):1014-5
AFFECTIONS
DERMATOLOGIQUES
NOBLES JP, DE
GENNES
C, BOUSQUET O. Skin
diseases related to hepatitis B vaccine.
Gastroenterol.Clin.biol 1997;21(1)
:87
Alopécie
WISE
RP,
KIMINYO
KP,
SALIVE
ME. Hair loss after
routine immunizations.
JAMA. 1997;278(14):1176-8
SEPKOWITZ
S
. Hair loss after immunization.
JAMA.
1998;279(2):117-8.
SUNBERG JP, SILVA KA, ZHANG W, SUNBERG BA,
EDWARDS K, KING LE, DAVIS RL, BLACK
S.
Recombinant human
hepatitis B vaccine initiating alopecia areata: testing
the hypothesis using the C3H/HeJ mouse
model. Vet Dermatol. 2009
Jan 17
Anétodermie
DAOUD MS, DICKEN
CH. Anetoderma after hepatitis B immunization in two
siblings. J.Am.Acad.Dermatol. 1997;36(5 Pt
1):779-780
Eczéma par
sensibilisation au
formaldéhyde
RING J.
Exacerbation of eczema by formalin-containing hepatitis B
vaccine in formaldehyde-allergic patients. Lancet
1986;522-523
Mc KENNA KE.
Eczematous reaction
to hepatitis B
vaccine. Contact Dermatitis.
1999 ;40(3):158-9
Erythème
noueux
MAGGIORE G,
GRIFEO S, MANZNI MD.
Erythema nodosum and hepatitis B virus infection.
J.Am.Acad.Dermatol.1983;9:602-603
DI GIUSTO CA,
BERNHARD JD. Erythema nodosum provoked by hepatitis B
vaccine. Lancet
1986;ii:1042
GOOLSBY PL.
Erythema nodosum after recombinant hepatitis B vaccine.
N.Engl.J.Med.
1989;21:1198-1199
ROGERSON ST
, NYE FJ. Hepatitis B vaccine associated with erythema nodosum
and polyarthritis. Br. Med.
J.1990;301:345
CASTRESANA-ISLA CJ,
HERRERA-MARTINEZ G,VEGA-MOLINA J. Erythema nodosum and
Takayasu’s arteritis after immunization with plasma
derived hepatitis B vaccine. J.
rhumatol.1999;20:1417-1418
Erythermalgie
RABAUD C. First
case of erythermalgia related to hepatitis B vaccination.
J.Rheumatol.1999;26(1):233-234
Erythème
polymorphe
FELDSHON SD,
SAMPLINER RE. Reaction to hepatitis B virus vaccine. Ann.
Inter. Med.
1984;100(1):156-157
WAKEEL RA, WHITE
MI. Erythema multiforme associated with hepatitis B
vaccine. Br. J. Dermatol.
1992;126:94-95
MILSTIEN JB,
KURITSKY JN. Erythema multiforme and hepatitis B
immunization. Arch.
Dermatol.1986;122:511-512
DI LERNIA V, LO
SOCCO G, BISIGHINI G.
Erythema multiforme
following hepatitis B vaccine. Pediatric Dermatol.
1994;4:363-364
LOCHE F, SCHWARZE HP, THEDENAT B, CARRIERE M,
BAZEX J.
Erythema multiforme
associated with hepatitis B
immunization. Clin Exp
Dermatol. 2000
;25(2):167-168.
Granulome
annulaire
GREZARD P.
Accidents de la vaccination contre l’hépatite B : à
propos de 9 cas observés de début 1994 à fin 1995. Thèse
LYON I. 1996:79-83
WOLF
F
,
GREZARD P
,
BERARD F
,
CLAVEL G
,
PERROT H
. Generalized granuloma annulare and hepatitis B
vaccination.
Eur J Dermatol.
1998 ;8(6):435-436
CRIADO
PR, DE OLIVEIRA RAMOS
R,
VASCONCELLOS
C,
JARDIM CRIADO
RF,
VALENTE
NY. Two case reports
of cutaneous adverse reactions following hepatitis B
vaccine: lichen planus and granuloma
annulare.
J Eur Acad Dermatol
Venereol. 2004;
18(5):603-6
Lichen
plan
CIACCO M, REBORA A.
Lichen planus following HB vaccination: a coincidence?
Br. J. Dermatol.
1990;122(3):424
TREVISAN G, STINCO
G. Lichen rubber planus following HB vaccination. Acta
Dermatol. Venereol.
1993;73:73
PUSEL B, WILL F,
GROSSHANS E. Lichen plan et vaccination contre l’hépatite
B. Nouv.
Dermatol.1994;130:1329-1330
AUBIN F, ANGONIN R,
HUMBERT P, AGACHE P. Lichen planus following hepatitis B
vaccination. Arch. Dermatol.
1994;130:1329-1330
LEPORT Y. Lichen
plan et vaccination contre l’hépatite B. Nouv. Dermatol.
1995; 14: 594
GREZARD P,
PHILIPPOT V, PERROT H. Lichen plan et vaccination contre
l’hépatite B. Nouv. Dermatol. 1995 ;14
:444-445
LEFORT A,
DACHARY D, VERGIER B, BOIRON G. Lichen plan et vaccination
anti-hépatite B. Ann. Dermatol.
Venereol.
1995;122:701-703
SAYWELL
CA
,
WITTAL RA
,
KOSSARD S
,
AUSTRALAS J. Lichenoid reaction to hepatitis B vaccination.
Dermatol.
1997;38(3):152-4
GISSEROT O, CARSUZAA F, MARLIER S, MORAND JJ, MARROT E. Lichen
planus after hepatitis B vaccination. 3 new cases.
Presse Med.
1997 ;26(16) :760
FERRANDO MF, DOUTRE MS, BEYLOT-BARRY M, DURAND
I, BEYLOT C.
Lichen planus
following hepatitis B
vaccination. Br J
Dermatol. 1998
;139(2):350.
|
|
LACOUR
JP. Hepatitis, the
vaccine, multiple sclerosis and lichen:
the story and its morale. Ann Dermatol
Venereol.
1998;125(6-7):395-7
REBORA A. Lichen planus
as a side effect of HBV vaccination.
Dermatology 1999;
198(1):1-2
BARDAZZI F, LANDI C,
ORLANDI C, NERI I, VAROTTI C. Graham
Little-Piccardi-Lasseur syndrome
following HBV vaccination. Acta derm
Venereol. 1999;79(1):93 SCHUPP P, VENTE
C. Lichen planus following hepatitis B
vaccination. Int J Dermatol.
1999;38(10):799-800.
AL-KHEINAIZAN
S.
Lichen planus occurring
after hepatitis B vaccination: a new
case. J Am Acad
Dermatol.
2001;45(4):614-5.
USMAN A,
KIMYAI-ASADI A, STILLER MJ, ALAM
M.
Lichenoid eruption
following hepatitis B vaccination: first
North American case
report. Pediatr Dermatol.
2001
;18(2):123-6.
DRAGO F, REBORA A.
Cutaneous immunologic reactions to
hepatitis B virus vaccine. Ann Internal
Med.
2002;136(10):780
DARAMOLA
OO, OGINBIYI AO, GEORGE
AO.
Lichen planus following
hepatitis B vaccination in an African
girl. Trop Doct.
2002;32(2):117-118
STAVRIANEAS
NG
,
KATOULIS AC
,
KANELLEAS A
,
HATZIOLOU E
,
GEORGAL S. Papulonodular lichenoid and
pseudolymphomatous reaction at the injection
site of hepatitis B virus
vaccination.
Dermatology
2002;205(2):166-8.
|
Lupus érythémateux cutané
GREZARD P.
Accidents de la vaccination contre l’hépatite B : à
propos de 9 cas observés de début 1994 à fin 1995. Thèse
LYON I. 1996:106-109
CHOFFRAY A, PINQUIER L, BACHELEZ H.
Exacerbation of lupus panniculitis following anti-hepatitis-B
vaccination.
Dermatology
2007;215(2):152-4.
Pemphigoide
bulleuse
ERBAGCI Z.
Childhood bullous
pemphigoid following hepatitis B
immunization. J Dermatol.
2002 Dec;29(12):781-5.
Psoriasis
MORRIS CA, OLIVIER PR, REYNOLDS F, SELKON JB. Intradermal
hepatitis B immunization with
yeast-derived vaccine : serological response by sex and
age. Epidemiol. Infect.
1989 ;103 :387-394
Morbidity and
mortality weekly report.
Safety of hepatitis B vaccine. J.Am.Med. Assoc.
1983;249:1812
AHERNE P, COLLINS
M. Psoriatic arthropathy. Irish Med J.
1995;88:72
Sclérodermie
en plaques
GREZARD P.
Accidents de la vaccination contre l’hépatite B : à
propos de 9 cas observés de début 1994 à fin 1995. Thèse
LYON I. 22 avril
1996:84-87
SCHMUTZ JL, POSTH
M, GRANEL F, TRECHOT P, BARBAUD
A.
Localized scleroderma after
hepatitis B vaccination. Presse Med.
2000;29(19):1046
TORRELO
A
,
SUAREZ J
,
COLMENERO I
,
AZORIN D
,
PERERA A
,
ZAMBRANO A
. Deep morphea after vaccination in two young
children.
Pediatr Dermatol.
2006
;23(5):484-7
Syndrome de
Gianotti-Crosti
GIAM YC,
TAY YK. Gianotti-Crosti syndrome: a review of 22
cases. J.Singapore Paediatr.Soc.
1993;35:139-146
TAY
YK.
Gianotti-Crosti syndrome following
immunization. Pediatr
Dermatol
. 2001 May-Jun;18(3):262.
ANDIRAN N, SENTURK GB, BUKULMEZ
G.
Combined
vaccination by measles and hepatitis B vaccines: a new
cause of Gianotti-Crosti
syndrome. Dermatology.
2002;204(1):75-6.
HAUG S, SCHNOPP C, RING J, FOLSTER-HOLST R,
ABECK D.
Gianotti-Crosti
syndrome following
immunization. Hautarzt.
2002;53(10):683-5.
KARAKAS M, DURDU M, TUNCER I, CEVLIK
F.
Gianotti-Crosti
syndrome in a child following hepatitis B virus
vaccination. J Dermatol.
2007;34(2):117-20.
AFFECTIONS
AUTO-IMMUNES ET CONNECTIVITES
Cryoglobulinémie
MATHIEU E, FAIN
O, KRIVITZKY A.
Cryoglobulinemia after hepatitis B
vaccination. N Engl J Med.
1996;335(5):355.
KRIVITZKY A,
GAUDOUEN Y, BENTATA M. OLSCHWANG M. Cryoglobulinémie après
vaccination contre l'hépatite B. Communication au congrès de
la société nationale française de médecine
interne.
Reims
; 8-10-1994
Diabète insulino-dépendant
CLASSEN JB.
Childhood
immunisation and diabetes
mellitus. N Z Med J.
1996;109(1022):195
CLASSEN
JB. The diabetes
epidemic and the hepatitis B vaccines. N Z Med J.
1996;109(1030):366.
PETOUSIS-HARRIS H, TURNER
N.
Hepatitis B
vaccination and
diabetes. N Z Med J.
1999;112(1093):303-304
GRAVES PM, BARRIGA KJ, NORRIS JM, HOFFMAN MR,
YU L, EISENBARTH GS, REWERS M.
Lack of association
between early childhood immunizations and beta-cell
autoimmunity. Diabetes
Care.
1999;22(10):1694-1697.
THIVOLET C, VIALETTES B, BOITARD C, BRINGER
J.
Absence of evidence
of a possible connection vaccination for hepatitis B and
the development of diabetes type 1. Report of a group of
ALFEDIAM experts. Diabetes Metab.
1999;25(5):441-445
Dermatomyosite et
polymyosite
FERNANDEZ-FUNEZ
A, POLO-ROMERO FJ.
Juvenile
dermatomyositis concomitant with hepatitis B
vaccination
. Med Clin (Barc). 1998
;111(17):675.
RAMIREZ-RIVERA
J, VEGA-CRUZ AM, JAUME-ANSELMI F.
Polymyositis: rare complication of hepatitis B vaccination. An
unusual cause of toxic shock syndrome. Bol Asoc Med
P R. 2003 Nov-Dec;95(6):13-6.
ALTMAN A,
SZYPER-KRAVITZ M, SHOENFELD Y.
HBV vaccine and
dermatomyositis: is there an
association? Rheumatol Int. 2008
Apr;28(6):609-12
Lupus erythémateux
disséminé (LED)
T
UDELA
P, M
ARTI S, BONAL
J. Systemic lupus erythematosus and
vaccination against hepatitis B. Nephron.
1992;62(2):236
MAMOUX V,
DUMONT C. Lupus érythémateux disséminé et vaccination contre
l’hépatite B. Arch. Pédiatr.
1994 ;1 :306-310
NUTINI MT.
Pharmacovigilance Hévac B Pasteur. J. Am Med Assoc. (supplément
hors série) 1987 : 5-7
GUISERIX J.
Systemic lupus erythematosus following hepatitis B vaccine.
Nephron. 1996;74(2):441
DELBREL X, FACH
J, NEAU D, LAMARQUE P, LONGY-BOURSIER M, LE BRAS M Poussée
lupique après vaccination contre l’hépatite B : un nouveau
cas. Rev Méd. Interne 1997 ;18 (suppl 2) poster
27 :160s
FINIELZ P,
LAM-KAM-SANG LF, GUISERIX
J.
Systemic lupus
erythematosus and thrombocytopenic purpura in two members of
the same family following hepatitis B vaccine. Nephrol Dial
Transplant. 1998;13(9):2420-1
BATTAFARANO DF and
al.
Antigen-specific antibody responses in lupus
patients following
immunization. Arthritis Rheum.
1998;41(10):1828-34.
|
|
SENECAL JL, BERTRAND C,
COUTLEE F. Severe exacerbation of systemic
lupus erythematosus after hepatitis B
vaccination and importance of pneumococcal
vaccination in patients with autosplenectomy:
comment on the article by Battafarano et al.
Arthritis Rheum.
1999;42(6):1307-8
HANSLIK T, VAILLANT JN,
AUDRAIN L, JUBAULT V, PRINSEAU J, BAGLIN A,
FLAHAUT A.
Systemic lupus erythematosus
and risk of hepatitis B vaccination: from level
of evidence to
prescription
. Rev Med Interne.
2000;21(9):785-90.
SHAPIRO E, KOPICKY
J.
Comment on the article "can
immunization precipitate connective tissue
disease? Report of 5 cases of systemic lupus
erythematosus and review of the
literature".
Semin. Arthritis Rheum.
2000;30(3):215-6
FINESCHI S. Can recombinant
anti-hepatitis B vaccine be a cause of systemic
lupus erythematosus? Lupus.
2001;10(11):830.
POIRRIEZ J. A preliminary
experiment of absorption of antinuclear
antibodies by the hepatitis B vaccine
components, in a case of neurolupus. Vaccine
2004, 22: 3166-3168
MARTINUC POROBNIC J, AVCIN T,
BOZIC B, KUHAR M, CUCNICS, ZUPANCIC M, PROSENC
K, KVEDER T, ROZMAN B.
Anti-phospholipid antibodies
following vaccination with recombinant
hepatitis B vaccine.
Clin Exp Immunol. 2005;
142(2): 377-80
SANTORO D, STELLA M, MONTALTO
G, CASTELLINO S.
Lupus nephritis after
hepatitis B vaccination: an uncommon
complication.
Clin Nephrol. 2007 Jan;
67(1):61-63.
KURUMA KA, BORBA EF, LOPES MH,
DE CARVALHO JF, BONFA E.
Safety and efficacy of
hepatitis B vaccine in systemic lupus
erythematosus.
Lupus. 2007;
16(5):350-4.
Myasthénie
BIRON P, MONTPETIT P,
INFANTE-RIVARD C, LERY L, Myasthenia gravis
after general anaesthesia and hepatitis B
vaccine. Arch.Intern.
med.1988;148:2685
DOMINGO V, AUTHIER FJ,
BACHOUD-LEVI AC,, GHERARDI RK,DEGOS JD. Should
hepatitis B vaccine be contra-indicated in
myasthenia gravis? Autoimmunity.
1999;29(2)139-140
LOUZIR B, OTHMANI S, BATTIKH
R, BEN ABDELHAFIDH N, TAALOUCHE L, BAHRI M.
Myasthenia after hepatitis B vaccination.
Therapie
2003;58(4):378-379
Périartérite noueuse
(PAN)
CUPPS TR, GOLDSMITH PK,
VOLKMAN DJ, GERIN JL, PURCELL RH,
FAUCI AS.
Activation of human peripheral
blood B cells following immunization with
hepatitis B surface antigen
vaccine.
Cell Immunol.
1984;86(1):145-54.
LE GOFF P, FAUQUERT P,YOUINOU
P, HOANG S. Périartérite noueuse après
vaccination contre l’hépatite B. Press. Med.
1988 ;17 :1763
Mc MAHON BJ, HEYWARD WL,
TEMPLIN DW, CLEMENT D, LANIER AP.
Hepatitis B-associated
polyarteritis nodosa in Alaskan Eskimos:
clinical and epidemiologic features and
long-term follow-up.
Hepatology. 1989
Jan;9(1):97-101.
GATEL A, CACOUB P,SBAI
A,MAISONNOBE T, LUNEL F,ELIASZEWICZ D,PIETTE
JC, GODEAU P. Périartérite noueuse systémique
après vaccination contre l’hépatite B. Rev.
Méd. Interne 1996 ;17(suppl.3) poster
119 :467s
KERLEAU JM, LEVESQUE H, LAIR
G, LECOMTE F, CARRARA O, COURTOIS
H.
Is hepatitis B vaccination a
new cause of necrotizing
vasculitis?
Rev Med Interne.
1997;18(6):491-2
DE KEYSER F, NAEYAERT JM,
HINDRYCKX P, ELEWAUT D, VERPLANCKE P, PEENE I,
PRAET M, VEYS E.
Immune-mediated pathology
following hepatitis B vaccination. Two cases of
polyarteritis nodosa and one case of pityriasis
rosea-like drug
eruption.
Clin Exp
Rheumatol. 2000
Jan-Feb;18(1):81-5.
SAADOUN D, CACOUB P, MAHOUX D,
SBAI A, PIETTE JC.
Postvaccine vasculitis: a
report of three
cases Rev
Med Interne. 2001 Feb;22(2):172-6.
BOURGEAIS AM, DORE MX, CROUE
A, LECLECH C, VERRET JL.
Cutaneous polyarteritis nodosa
following hepatitis B
vaccination
. Ann Dermatol Venereol.
2003 Feb;130(2 Pt
1):205-7
Syndrome de
Gougerot-Sjögren
TOUSSIROT E, LOHSE A, WENDLING
D, MOUGIN C.
Sjögren's syndrome occurring
after hepatitis B
vaccination.
Arthritis Rheum. 2000
Sep;43(9):2139-40
Syndrome
néphrotique
NUTINI
MT
, MARIE FN, LOUC C, TRON F. Hepatitis B vaccine
clinical experience and safety. Lancet
1985 ;ii :1301
MACARIO F, FREITAS L, CORREIA
J, CAMPOS M. Nephrotic syndrome after
recombinant hepatitis B vaccine. Clin. Nephrol.
1995;43:349
OZDEMIR S, BAKKALOGLU A, ORAN
O.
Nephrotic syndrome associated
with recombinant hepatitis B vaccination: a
causal relationship or just a mere
association?
Nephrol Dial Transplant.
1998
Jul;13(7):1888-9.
ISLEK I, CENGIZ K, CAKIR M,
KUCUKODUK S.
Nephrotic syndrome following
hepatitis B
vaccination.
Pediatr Nephrol. 2000
Jan;14(1):89-90.
Thyroidites auto-immunes
(Thyroïdite de Hashimoto, maladie de
Basedow)
TOFT I, LARSEN S, TOFT
H. Subacute thyroiditis after hepatitis B
vaccination. Endocr. J. 1998 Feb ;
45 (1) :
135.
YU O, BOHLKE K, HANSON CA,
DELANEY K, REES TG, ZAVIKOVSKY A, RAY P,
MULLOLY J, BLACK SB, BENSON P, THOMSON WW,
DAVIS RL, JACKSON LA.
Hepatitis B vaccine and risk
of autoimmune thyroid disease: a Vaccine Safety
Datalink study.
Pharmacoepidemiol Drug
Saf. 2007
Jul;16(7):736-45.
Vascularites
COCKWELL P, ALLEN MB, PAGE RL.
Vasculitis related to hepatitis B vaccine. Br.
Med. J.
1990;301:1281
CARMELI Y, OREN R. Hepatitis B
vaccine side-effect. Lancet 1993;341:
250-251
ALLEN MB, COCKWELL P, PAGE RL.
Pulmonary and cutaneous vasculitis following
hepatitis B vaccination. Thorax
1993;48:580-581
CASTRESANA-ISLA CJ,
HERRERA-MARTINEZ G, VEGA-MOLINA
J.
Erythema nodosum and
Takayasu's arteritis after immunization with
plasma derived hepatitis B
vaccine.
J Rheumatol. 1993
;20(8):1417-8.
KRIVITZKY A, GAUDOUEN Y,
BENTATA M, OLSCHWANG M. Cryoglobulinémie après
vaccination contre l’hépatite B. Communication
au congrès de la société nationale française de
médecine interne. Reims ;8-10 1994
LE HELLO C, COHEN P, GUIILEVIN
L. Vascularite leucocytoclasique après une
vaccination contre l’hépatite B. Rev. Med.
Inter. 1995 ;16 :poster
174
GREZARD P. Accidents de la
vaccination contre l’hépatite B : à propos de 9
cas observés de début 1994 à fin 1995.
Thèse
LYON I.
1996:92-99
KERLEAU JM, LEVESQUE H, LAIR
G, LECOMTE F, CARRARA O, COURTOIS
H.
Is hepatitis B vaccination a
new cause of necrotizing
vasculitis?
Rev Med Interne.
1997;18(6):491-492.
DRUCKER Y, PRAYSON RA, BAGG A,
CALABRESE LH.
Lymphocytic Vasculitis
Presenting as Diffuse Subcutaneous Edema After
Hepatitis B Virus
Vaccine.
J Clin Rheumatol.
1997;3(3):158-161.
VANOLI M, GAMBINI D, SCORZA
R.
A case of Churg-Strauss
vasculitis after hepatitis B
vaccination.
Ann Rheum Dis.
1998;57(4):256-7
MASSE I, DESCOFFRES
MC.
Hypersensitivity vasculitis
after hepatitis B
vaccination
Presse Med.
1998;27(20):965-6
GRASLAND A, LE MAITRE F,
POUCHOT J, HAZERA P, BAZIN C, VINCENEUX
P.
Adult-onset Still's disease
after hepatitis A and B
vaccination?
Rev Med Interne. 1998
;19(2):134-6
BUI-QUANG D, THOMAS E, RIOLS
M, LEVILLAIN P, PICAUD D, SECHET A, BARON M,
VEROVE C.
Cutaneous vasculitis after
hepatitis B vaccination with recombinant
vaccine in a renal transplant
patient
. Presse Med. 1998;
12;27(26):1321-1323.
CASTRESANA-ISLA CJ,
HERRERA-MARTINEZ G,VEGA-MOLINA J. Erythema
nodosum and Takayasu’s arteritis after
immunization with plasma derived hepatitis B
vaccine. J.
rhumatol.1999;20:1417-1418
LE HELLO C, COHEN P, BOUSSER
MG, LETELLIER P, GUILLEVIN L.
Suspected hepatitis B
vaccination related
vasculitis.
J Rheumatol.
1999;26(1):191-4.
SAADOUN D, CACOUB P, MAHOUX D,
SBAI A, PIETTE JC.
Postvaccine vasculitis: a
report of three
cases Rev
Med Interne.
2001;22(2):172-6
ZAAS A, SCHEEL P, VENBRUX A,
HELLMANN DB.
Large artery vasculitis
following recombinant hepatitis B vaccination:
2 cases.
J Rheumatol.
2001;28(5):1116-20.
BERETTA L, CARONNI M, VANOLI
M, SCORZA R.
Churg-Strauss vasculitis with
brain involvement following hepatitis B
vaccination.
Clin Exp Rheumatol. 2001
; 19(6):757.
CHAVE T, NEAL C, CAMP
R.
Henoch-Schönlein purpura
following hepatitis B
vaccination.
J Dermatolog Treat.
2003;14(3):179-81.
MIRON D, FINK D, HASHKES
PJ.
Kawasaki disease in an infant
following immunisation with hepatitis B
vaccine.
Clin Rheumatol.
2003;22(6):461-3.
|
AFFECTIONS
HEMATOLOGIQUES
Syndrome
d’Evans (anémie et thrombopénie
auto-immunes)
MARTINEZ E,
DOMINGO P. Evan’s syndrome triggered by recombinant hepatitis
B vaccine.
Clin. Infec. Dis. 1992;15:1051
LLIMINANA C,
SOLER JA, MELO M, ROIG I.
Hemolytic
anemia and thrombocytopenic purpura after the administration of
the recombinant hepatitis B
vaccine. Med Clin (Barc).
1999;113(1):39.
Thrombopénie (Baisse des plaquettes
)
POULLIN P,
GABRIEL B. Thrombocytopenic purpura after recombinant hepatitis
B vaccine.
Lancet 1994;344:1293
MEYBOOM RHB,
FUCIK H, EDWARDS IR. Thrombocytopenia reported in association
with hepatitis B and A vaccines. Lancet 1995;345
(8965):1638
RONCHI F,
CECCHI P, FALCIONI F, MARSCIANI A, MINAK G, MURATORI G, TAZZARI
PL, BEVERINI S.
Thrombocytopenic purpura as adverse reaction
to recombinant hepatitis B
vaccine. Arch Dis
Child. 1998;78(3):273-274.
NEAU D, BONNET
F, MICHAUD M, PEREL Y, LONGY-BOURSIER M, RAGNAUD JM, GUILLARD
JM.
Immune
thrombocytopenic purpura after recombinant hepatitis B vaccine:
retrospective study of seven
cases. Scand J Infect
Dis. 1998;30(2):115-8.
MULLER A, KERTZSCHER F, KIEFEL V, LENK H. Thrombocytopenic
purpura: adverse reaction to a combined immunisation
(recombinant hepatitis B and measles-mumps-rubella-vaccine) and
after therapy with Co-trimoxazole.
Eur J Pediatr. 1999;158 Suppl
3:S209-10.
MAEZONO R,
ESCOBAR AM
.Thrombocytopenic purpura after hepatitis B
vaccine. J Pediatr (Rio J).
2000;76(5):395-8.
CONESA V, NUNEZ
Mf, NAVARRO JF, MOMPEL A, RUIZ J, GOMEZ
A.
Thrombocytopenic Purpura after Recombinant
Hepatitis B Vaccine. A rare
association. Haematologica.
2001;86(3)E09
NUEVO H,
NASCIMENTO-CARVALHO CM, ATHAYDE-OLIVEIRA CP, LYRA I, MOREIRA
LM.
Thrombocytopenic purpura after hepatitis B
vaccine: case report and review of the
literature. Pediatr Infect Dis
J. 2004;23(2):183-4.
POLAT A, AKCA
H, DAGDEVIREN E.
Severe
thrombocytopenia after hepatitis B vaccine in an infant from
Turkey. Vaccine. 2008
Oct 14.
Pancytopénie
(Anémie, thrombopénie et leucopénie)
ASHOK SHENOY K,
PRABHA ADHIKARI MR, CHAKRAPANI M, SHENOY D, PILLAI
A.
Pancytopenia
after recombinant hepatitis B vaccine, an Indian case
report. Br J Haematol.
2001;114(4):955.
VIALLLARD JF,
BOIRON JM, PARRENS M, MOREAU JF, RANCHIN V, REIFFERS J, LENG B,
PELLEGRIN JL.
Severe
pancytopenia triggered by recombinant hepatitis B
vaccine. Br J Haematol.
2000;110(1):230-3.
AFFECTIONS
HEPATIQUES ET
DIGESTIVES
Hépatite
aiguë
RANIERI VM.
DELL’ERBA A, GENTILE A, BRUNO F, LA GIOIA V,SPAGNOLO A, SACCO
R,CARUSO G,ANTONACI S, SCHIRALDI G, BRIENZA A. Liver
inflammation and acute respiratory distress syndrome in a
patient receiving hepatitis B vaccine: a possible relationship?
Intensive Care Med. 1977; 23(1):
119-121
SNIDER GB.
GOGATE SA. A possible systemic reaction to hepatitis B vaccine.
J. Am. Med. Assoc.
1985;253:1260-1261
RAJENDRAN V,
BROOKS AP. Symptomatic reaction to hepatitis B vaccine with
abnormal liver function values. Br. Med. J.
1985;290(6480):1476
GERMANAUD J,
CAUSSE X, HI TRINH D, PFAU-FANDARD B, TREPO C. A case of severe
cytolysis after hepatitis B vaccination. Am. J. Med.
1995;98:595-596
LILIC D, GHOSH SK. Liver dysfunction and DNA antibodies after
hepatitis B vaccination.
Lancet 1994;344:1292-1293
GREEN C,
LAKSHMIPATHI T. A case of hepatitis related to etretinate
therapy and hepatitis B vaccine. Dermatologica
1991;182:119-120
E
VANS AA, LONDON
WT. Hepatitis B
vaccine and liver problems in U.S. children less
than 6 years old. Epidemiology.
1999;10(6):790-791.
LASHERAS CARBAJO
MD, PALACIOS DIEZ M, GONZALEZ DIEGO P,
MARTIN
SCAPA MA, CANO RUIZ A,
ASENSIO VEGAS A. A case of
intense cytolysis following the administration of a
hepatitis B vaccine. Rev Clin Esp.
1999;199(1):49-50
GEIER DA, GEIER MR.
Hepatitis B vaccination and adult associated gastrointestinal
reactions: a follow-up analysis.
Hepatogastroenterology
2002;49(48):1571-1575
Hépatite
auto-immune
LILIC D,
GHOSH SK.
Liver dysfunction
and DNA antibodies after hepatitis B
vaccination. Lancet.
1994;344(8932):1292-1293
Maladie de
Crohn et Rectocolite
hémorragique
Fibromyalgie et
Syndrome de fatigue
chronique
O’SULLIVAN SJ.
Alleged link between hepatitis B vaccine ans chronic
fatigue syndrome. Can Med. Assoc. J.
1992;147:3999
DELAGE G, SALIT I,
PENNIE R, ALLARY M, DUVAL B, WARD B. The possible
relation between hepatitis B vaccination and chronic
fatigue syndrome. Union Med.
Can. 1993;122:278-279
ANONYME
Report of the
working group on the possible relationship between
hepatitis B vaccination and the chronic fatigue
syndrome. CMAJ.
1993;149(3):314-319.
DUCLOS
P. Safety of immunisation
and adverse events following vaccination against
hepatitis B.
Expert Opin Drug
Saf. 2003;2(3):225-31
ABLIN
JN,
SHOENFELD
Y,
BUSKILA
D.
Fibromyalgia, infection and
vaccination: Two more parts in the etiological
puzzle.
J
Autoimmun. 2006;27(3):145-52.
APPEL
S,
CHAPMAN
J,
SHOENFELD
Y. Infection and
vaccination in chronic fatigue syndrome: myth or
reality?
Autoimmunity. 2007;40(1):48-53.
NANCY
AL,
SHOENFELD
Y. Chronic fatigue
syndrome with autoantibodies-the result of an augmented
adjuvant effect of hepatitis-B vaccine and silicone
implant.
Autoimmun
Rev. 2008
Oct;8(1):52-5.
EXLEY
C,
SWARBRICK
L,
GHERARDI
RK,
AUTHIER
FJ.
A role for the body burden of aluminium in vaccine-associated
macrophagic myofasciitis and chronic fatigue syndrome.
Med Hypotheses. 2009 Feb;72(2):135-9.
Myofasciite à
macrophages
(
Une bibliographie complète est disponible sur le site de
l’association E3M des personnes atteintes de myofasciite à
macrophages
(http://www.myofasciite.fr/
). L’article princeps
est :
GHERARDI RK, COQUET M, CHERIN P, BELEC L, MORETTO P, DREYFUS
PA, PELISSIER JF, CHARIOT P, AUTHIER FJ. Macrophagic
myofasciitis lesions assess long-term persistence of
vaccine-derived aluminium hydroxide in
muscle. Brain 2001
;124(9):1821-1831
Ataxie
cérébelleuse
DEISENHAMMER F,
POHL P, BOSCH S, SCHMIDAUER C. Acute cerebellar ataxia
after immunisation with recombinant hepatitis B vaccine.
Acta Neurol. Scand. 1994; 89:
462-3.
Encéphalite,
Leuco-encéphalite, Encéphalomyélite
(ADEM)
MANNA R,DE SANTIS,
OLIVIERO A, CARNEVALE A, CAPUTO S, PAHOR M, LAUDISIO A,
GASBARRINI G. Leukoencephalitis after recombinant
hepatitis B vaccine. J.Hepatol.
1996;24(6):764-765
TOURBAH A, GOUT O, LIBLAU R, LYON-CAEN O,
BOUGNIOT C, IBA-ZIZEN MT, CABANIS
EA.
Encephalitis after
hepatitis B vaccination: recurrent disseminated
encephalitis or MS? Neurology.
1999;53(2):396-401.
KONSTANTINOU D,
PASCHALIS C, MARAZIOTIS T, DIMOPOULOS P, BASSARIS H,
SKOUTELIS A. Two episodes of leukoencephalitis associated
with recombinant Hepatitis B vaccination in a single
patient. Clinical
Infectious Diseases.
2001;33:1772-1773
CABRERA-GOMEZ JA, ECHAZABAL-SANTANA N,
GARCIA-GONZALES L, RAMOS CEDENO AM, RODRIGUEZ ROQUE MO, LOPEZ
HERNANDEZ O, CABRERA NUNEZ JA, GONZALES DE LA NUEZ J, TELLEZ
L.
A severe episode in
a patient with recurrent disseminated acute encephalitis
due to vaccination against hepatitis B. For or against
vaccination? Rev Neurol.
2002;34(4):358-363.
HUYNH
W,
CORDATO
DJ,
KEHDI
E,
MASTERS
LT,
DEDOUSIS
C. Post-vaccination
encephalomyelitis: literature review and illustrative
case.
J Clin
Neurosci. 2008;15(12):1315-1322
Myélite
transverse
MAHASSIN F,
ALGAYRES JP, VALMARY J, BILIH, COUTANT G, BEQUET D, DALY
JP. Myélite aiguë après vaccination contre l'hépatite B.
Presse Med. 1993;
22:1997-1998
TREVISANI F,
GATTINARA GC, CARACENI P, BERNARDI M, ALBERTONI F.
Transverse myelitis following hepatitis B vaccination. J.
Hepatol.
1993;19:317-318
TARTAGLINO LM, HEIMAN-PATHERSON T, FRIEDMAN DP, FLANDERS
AE. MR imaging in
a case of postvaccination myelitis. AJNR Am J
Neuroradiol 1995; 16:581-582
SENEJOUX A, ROULOT
D, BELIN C,TSKIRIS L, RAUTUREAU J, COSTE T. Acute
myelitis after immunization against hepatitis B with
recombinant vaccine. Gastroenterol Clin Biol. 1996 ;20(4)
:401-402
SONG HK, KIM HC, YUN
YH.
Acute Myelitis
after hepatitis B
vaccination. J Korean Med
Sci. 1997;12(3):249-51
RENARD JL,
GUILLAMO JS, RAMIREZ JM, TAILLIA H, FELTEN D, BUISSON
Y.
Acute transverse cervical myelitis following hepatitis B
vaccination. Evolution of anti-HBs antibodies.
Presse Med. 1999;28(24):
1290-1292.
INIGUEZ C,
MAURI JA, LARRODE P, LOPEZ DEL VAL J, JERICO I, MORALES
F.
Acute transverse myelitis secondary to hepatitis B
vaccination Rev Neurol.
2000;31(5):430-432.
KARAAALI-SAVRUN F, ALTINTAS A, SAIP S, SIVA
A.
Hepatitis B vaccine
related-myelitis? Eur J Neurol.
2001;8(6):711-715
FONSECA LF, NOCE TR, TEIXEIRA ML, TEIXEIRA AL Jr,
LANA-PEIXOTO
MA.
Early-onset acute transverse myelitis following hepatitis B
vaccination and respiratory infection: case report.
Arq Neuropsiquiatr. 2003;61(2A):265-268.
Névralgie
amyotrophique de l’épaule de Parsonage et
Turner
NUTINI MT.
Pharmacovigilance Hévac B Pasteur. J.Am. Med. Assoc.
(supplément hors série) 1987:
5-7
REUTENS DC, DUNNE
JW, LEATHER H. Neuralgic amyotrophy following recombinant
DNA hepatitis B vaccination. Muscle and nerve 1990; 657:
461
VITAL C, VITAL A, GBIKPI-BENISSAN G, LONGY-BOURSIER M, CLIMAS
MT, CASTAING Y, CANRON MH, LE BRAS M, PETRY
K.
Postvaccinal inflammatory neuropathy: peripheral nerve biopsy
in 3 cases.
J Peripher Nerv Syst.
2002;7(3):163-167.
JASTANIAH WA,
DOBSON S
,
LUGSDIN JG
,
PETTY RE
. Complex regional pain syndrome after hepatitis B
vaccine.
J Pediatr.
2003;143(6):802-804
BANTZ PM, PEISER C,
GRONEBERG DA.
Peripheral
neurological symptoms after hepatitis B virus
vaccination.
QJM.
2003;96(8):611
Paralysie
faciale
SHAW FE, GRAHAM DJ,
GUESS HA, MILSTIEN JB, JOHNSON JM, SCHATZ GL, HADLER SL,
KURITSKY JN, HINER EE, BREGMAN DJ, MAYNARD JE.
Postmarketing surveillance for neurological adverse
events reported after hepatitis
vaccination. Am. J.
Epidemiol.
1988;127:567-580
GANRY O, LERAILLER
F, VERCELLETTO M, CHIFFOLEAU A, LAROUSSE C. Peripherical
facial paralysis following vaccination against hepatitis
B. Apropos of a case. Therapie.
1992;47(5):437-438
Sclérose en plaques (SEP
)
|
:
|
HERROELEN L, DE KEYSER
J, EBINGER
G. Central-nervous-system
demyelination after immunisation with
recombinant hepatitis B vaccine. Lancet.
1991 Nov 9;338(8776):1174-5.
NADLER
JP. Multiple sclerosis
and hepatitis B vaccination. Clin Infect
Dis. 1993 ;17(5):928-9.
KAPLANSKI G, RETORNAZ F,
DURAND J, SOUBEYRAND
J. Central
nervous
system
demyelination after vaccination against
hepatitis B and HLA haplotype. J Neurol
Neurosurg Psychiatry.
1995;58(6):758-9.
CAMPINS
MARTI M, MORAGA LLOP
FA.
Hepatitis B and multiple sclerosis. An.Esp
Pediatr.
1998;49(6):555-557
HALSEY
NA,
DUCLOS
P,
VAN
DAMME
P,
MARGOLIS
H.
Hepatitis B
vaccine and central nervous system
demyelinating diseases. Viral Hepatitis
Prevention Board
Pediatr Infect Dis
J. 1999;18(1):23-4.
DIEGO
NUNEZ MA, GONZALEZ MENENDEZ
AE
Vaccination against
hepatitis B and multiple
sclerosis An Esp Pediatr.
1999;50(1):97.
HALL A,
KANE M, ROURE C, MEHEUS
A.
Multiple sclerosis and
hepatitis B
vaccine? Vaccine.
1999;17(20-21):2473-5.
SOUBEYRAND B, BOISNARD
F, BRUEL M, DEBOIS H, DELATTRE D,
GAUTHIER A, SOUM S, THEBAULT
C. Central nervous
system demyelinating disease following
hepatitis B vaccination with GenHévac B.
Review of ten years of spontaneous
notifications (1989-1998). Presse Med.
2000;29(14):775-80
TERNEY
D, BENICZKY S, BARSI P, KONDAKOR I,
PERENYI J, FALUDI B, SZAPPER M, VECSEI
L.
Multiple sclerosis after
hepatitis B vaccination in a 16-year-old
patient. Chin Med J (Engl).
2006;119(1):77-9.
Sclérose latérale amyotrophique
(SLA
)
JERUSALEM F.
Amyotrophische lateralsklerose und
hepatitis-B-impfung.
Deutsch Med Wochensch
1987;
45:1757.
Surdité
brusque
BONFILS P, BIACABE
B,POTARD G, AIDAN D. Fluctuant perception
hearing loss after hepatitis B vaccine.
Ann. Otolaryngol Chir Cervicofac.
1996;113(6):359-361
ORLANDO MP, MASIERI S, PASCARELLA MA, CIOFALO
A, FILIACI F. Sudden hearing loss in childhood
consequent to hepatitis B vaccination : a
case report.
Ann
N Y Acad Sci.
1997;830:319-321
DE
JONCKJER PH, DE SURGERES
GG.
Acute tinnitus and permanent audio-vestibular
damage after hepatitis B vaccination. Int
Tinnitus J. 2001;7(1):59-61
Syndrome de Guillain-Barré et
Polyradiculonévrite
RIBERA EF, DUTKA
AJ. Polyneuropathiy associated with
administration of hepatitis B vaccine. N Eng J
Med. 1983;8:614.
SHAW FE, GRAHAM DJ,
GUESS HA, MILSTIEN JB, JOHNSON JM, SCHATZ
GL, HADLER SL, KURITSKY JN, HINER EE,
BREGMAN DJ, MAYNARD JE. Postmarketing
surveillance for neurological adverse
events reported after
hepatitis
vaccination. Am.
J. Epidemiol.
1988;127:567-580
TUOHY PG. Guillain Barré
syndrome following immunisation with
synthetic hepatitis B vaccine. New
Zealand Med J 1989 ; 102 : 114-115.
LIN
JJ. A rare association between hepatitis
B virus vaccination and Guillain Barré
syndrome - a case report. Chin J
Gastroenterol 1989;6:229-232.
KAKAR
A,
SETHI PK.
Guillain Barre syndrome associated with
hepatitis B vaccination. Indian J Pediatr.
1997;64(5):710-2.
CREANGE
A
,
TEMAM G, LEFAUCHEUR
JP.
Lumbosacral acute demyelinating polyneuropathy
following hepatitis B
vaccination.
Autoimmunity.
1999;30(3):143-146
WU
Z,
WU H, WANG Q, et al.
A Case-control Study on Guillain-Barre Syndrome
in Children of North China., Zhonghua Yu Fang
Yi Xue Za Zhi. 1999 Sep;33(5):279-81.
(Chinese)
SINSAWAIWONG
S,
THAMPANITCHAWONG P. Guillain-Barré
syndrome following recombinant hepatitis
B vaccine and literature review. J Med
Assoc Thai. 2000;
83(9):1124-1126
SINDERN E,
SCHRODER JM, KRISMANN M, MALIN JP. Inflammatory
polyradiculoneuropathy with spinal cord
involvement and lethal [correction of letal]
outcome after hepatitis B vaccination. J Neurol
Sci.
2001;186(1-2):81-85.
SETI
NK,
Guillain Barré syndrome following
vaccination with hepatitis B vaccine. J
Assoc Physicians India. 2002;
50:989
KHAMAISI M. Guillain
Barré syndrome following hepatitis B
vaccination. Clin Exp Rheumatol.
2004;22(6):767-70.
SOUAYAH
N. Guillain-Barré
syndrome after vaccination in United
States a report from the CDC/FDA Vaccine
Adverse Event Reporting
System.
Vaccine. 2007;25(29):5253-5255.
|
|
|
|
Autres affections
neurologiques
HARO S. Convulsion
associated with fever following hepatitis
B vaccination. J. Paediatr. Child Health
1990; 26:
65.
HARTMANN S. Convulsion
associated with fever following hepatitis
B vaccination. J Paediatr Child Health.
1990;26(1):65
KAYGUSUZ
S, ERDEMOGLU AK, KOKSAL
I.
Afebrile convulsion in
an adult after recombinant hepatitis B
vaccination. Scand J Infect
Dis.
2002;34(4):314-5.
MARSAUDON E, BARRAULT
MF. Meningeal reaction after vaccination
against hepatitis B. Presse Med.
1996;25(32):1561-1562
HEINZLEF O,MOGUILEWSKI
A, ROULLET E. Acute aseptic meningitis
after hepatitis B vaccination. Presse Med
1997;26(7):328
MAILLEFERT
JF, FARGE P, GAZET-MAILLEFERT MP,
TAVERNIER C
Mental nerve neuropathy
as a result of hepatitis B
vaccination. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 1997
Jun;83(6):663-4.
PIRMOHAMED M, WINSTANLEY
P. Hepatitis B vaccine and neurotoxicity.
Postgrad Med
J.1997;73(861):462-463
|
|
AFFECTIONS
OPHTALMOLOGIQUES
ARYA SC. Ophtalmic
complications of vaccines against hepatitis B virus.
Ophtalmol
1997;21(3):177-178
Epithéliopathie en
plaques
SINGH VK,KALRA K,YAMAKI K, ABE T, DONOSO L, SHINOHARA T.
Molecular mimicry between a uveitopathogenic site of S-antigen
and viral peptides : induction of experimental autoimmune
uveitis in Lewis rats. J.Immunol.1990;144:1282-1287
BREZIN
AP,LAUTIER-FRAU M,HAMEDANI M, ROGEAUX O, LEHOANG P.
Visual loss and eosinophilia after recombinant hepatitis
B Vaccine. Lancet
1993;28:563-4
BREZIN AP,
MASSIN-KOROBELNIK P, BOUDIN M, GAUDRIC A, LEHOANG P.
Acute posterior multifocal placoid pigment epitheliopathy
after hepatitis B vaccine. Arch. Ophtalmol.
1995;113:297-300
BOURGES JL, PISELLA PJ, LAURENS C, LIMON
S.
Multifocal placoid
epitheliopathy and anti-hepatitis B
vaccination J Fr
Ophtalmol.
1998;21(9):696-700
Neuropapillite
BERKMAN N, BENZARTI
T, DHAOUI R, MOULY P. Neuropapillite bilatérale au
décours de la vaccination contre l’hépatite virale B.
Presse Méd. 1996;25:1301
Névrite
optique
SHAW FE,
GRAHAM DJ, GUESS HA, MILSTIEN JB, JOHNSON JM, SCHATZ GL,
HADLER SL, KURITSKY JN, HINER EE, BREGMAN DJ, MAYNARD
JE.
Postmarketing surveillance for neurological adverse events
reported after hepatitis vaccination.
Am. J. Epidemiol.
1988;127:567-580
ALABITAR S,
BOURGEON B, GENIN R, FEN-CHONG M, N'GUYEN P, SERVEAUX MO,
ATCHIA H, SCHOHN D., Bilateral retrobulbar optic neuritis
with hepatitis B vaccination. Nephrol Dial Transplant.
1997 ;12(10):2169-2170
FLEDELIUS HC.
Unilateral papilloedema after hepatitis B vaccination in a
migraine patient. A case report including forensic aspects.
Acta Ophthalmol Scand.
1999;77(6):722-724.
Occlusion de la
veine centrale de la
rétine
DEVIN F,
ROQUES G, DISDIER P, RODOR F, WEILLER PJ.
Occlusi
on of central retinal vein after hepatitis B
vaccination. Lancet 1996;
347:1626
GRANEL B, DISDIER
P, DEVIN F, SWIADER L, RISS JM, COUPIER L, HARLE JR, JOUGLARD
J, WEILLER PJ.
Occlusion of the central retinal vein after vaccination against
viral hepatitis B with recombinant
vaccines.
4 cases. Presse Méd. 1997;
26(2) :62-65
BERKMAN N. Un cas
d’occlusion parcellaire et unilatérale de la veine
centrale de la rétine au décours d’une vaccination contre
l’hépatite B. Presse Méd. 1997;26(14)
:670
Uvéite
postérieure
FRIED M, CONEN D,
CONZELMANN M, STEINEMANN E. Uveitis after hepatitis B
vaccination. Lancet 1987;12:631-632
MURRAY
PI, PRASAD J, RAHI AH. Status of hepatitis B virus in the
aetiology of uveitis in Great Britain. Br. J. Ophtalmol.
1983;67:685-687
Taches blanches
multiples évanescentes
BAGLIVO E,
SAFRAN AB, BORRUAT FX.
Multiple evanescent white dot syndrome after hepatitis B
vaccine. Am J.
Ophtalmol.1996;122(3):431-432
AFFECTIONS RHUMATOLOGIQUES
Arthrites
réactionnelles
CHRISTIAN B, HELIN
P. Reactive arthritis following vaccination against
hepatitis B. Ugeskr Laeger
1987;149(28):1882
HACHULLA E,
HOUVENAGEL E, MINGUI A, VINCENT G, LAINE A. Reactive
arthritis after hepatitis B vaccination.
J.Rheumatol.1990;17:1250-1251
ROGERSON ST
, NYE FJ. Hepatitis B vaccine associated with erythema nodosum
and polyarthritis. Br. Med.
J.1990;301:345
BIASI D, DE SANDRE
G, BAMBARA LM, CARLETTO A, CARAMASCHI P, ZANONI G,
TRIDENTE G. A new case of reactive arthritis after
hepatitis B vaccination. Clinic. and Experimental
Rheumatology
1991;11(2):215
BIASI D, CARLETTO
A, CARAMASCHI P, FRIGO A, PACOR ML, BEZZI D, BAMBARA LM.
Rheumatological manifestations following hepatitis B
vaccination. Report of two clinical cases. Recenti
Progressi in Med. 1994; 85
:438-440
HASSAN W, OLDHAM R.
Reiter’s syndrome and reactive arthritis in health care
workers after vaccination.
Br.Med.J.1994;309:94
FRASER PA, WILSON
JD. Reiter’s syndrome attributed to hepatitis B
immunization. Br Med.J.
1994;309:1513
BIRLEY HD, ARYA OP.
Hepatitis B immunisation and reactive arthritis. Br. Med.
J. 1994;309(6967):1514
GROSS K, COMBE C, KRUGER K, SCHATTENKIRCHNER M. Arthritis after
hepatitis B vaccination: report of three cases.
Scand. J.
Rheumatol.1995;24 :50-2
CATHEBRAS, CARTRY
O,LAFAGE-PROUST H,LAUWERS A,ACQUART S,THOMAS T,ROUSSET H.
Arthritis, hypercalcemia and lytic bone lesions after
hepatitis B
vaccination. J.
Rheumatol.
1996;23(3):558-560
Polyarthrite
Rhumatoïde
RAU R, KARGER T,
HERBORN G.
Two cases of chronic
polyarthritis after hepatitis vaccination. Z Rheumatol.
1984;43:213
ROGERSON ST
, NYE FJ. Hepatitis B vaccine associated with erythema nodosum
and polyarthritis. Br. Med.
J.1990;301:345
SYMMONS DPM, CHAKRAVARTY K. Can immunization
trigger rheumatoid arthritis? Ann Rheumatol.
Dis.1993;52:843-844
VAUTIER G, CARTY
JE. Acute sero-positive rheumatoid arthritis occuring
after hepatitis B vaccination. Br.J.Rheumatol. 1994
;33:991-998
BANNWARTH B.
Drug-induced rheumatic
disorders.
Rev Rhum
Engl Ed. 1996 Nov;63(10):639-647
BRACCHI M, ZOPPINI
A. Polyarthritis associated with hepatitis B vaccination.
Br.J.Rheumatl.
1997;36(2):300-301
TREVES R. LACOSTE L, BONTOUX D, PITROU E, BERIN P, BONNET C.
Erosive nodular rheumatoid arthritis triggered by hepatitis B
vaccination. Presse Méd.
1997;26 (14):670
SOUBRIER M, DUBOST
JJ, BIELSA C, RISTORI JM, BUSSIERE JL. Polyarthrite
érosive déclenchée par une vaccination contre l'Hépatite
B. Presse Méd. 1997;
26(2):75
POPE JE, STEVENS A,
HOWSON W, BELL DA: The development of rheumatoid
arthritis after recombinant hepatitis B vaccination. J.
Rheumatology 1998 ;25 (9)
:1687-1693
SEBAG O, BOLLA G,
BEBIN B, SEBAG F.
Exacerbation
of chronic juvenile arthritis induced by hepatitis B
vaccination. Arch Pediatr.
1998;5(9):1046.
MAILLEFERT J
F.
SIBILIA
J,
TOUSSIROT
E,
VIGNON
E,
ESCHARD
JP,
LORCERIE
B,
JUVIN
R,
PARCHIN-GENESTE
N,
PIROTH
C,
WENDLING
D,
KUNTZ
JL,
TAVERNIER
C,
GAUDIN
P: Rheumatic disorders
developed after hepatitis B
vaccination.
Rheumatology
(Oxford). 1999;38(10):978-983.
FISHER MA, EKLUND
SA, JAMES SA,LIN X. Adverse events associated with
hepatitis B vaccine in US. Children less than six years
of age, 1993 and 1994. Annals Epidemiol. 2001;11
(1):13-21
Spondylarthrite
ankylosante
Glomérulonéphrite
NUTINI MT,
MARIE FN, LOUCQ C, TRON F. Hepatitis B vaccine : clinical
experience and safety. Lancet 1982,2:
1301 .
CARMELY Y, OREN R.
Hepatitis B side-effet. Lancet
1993;341(8839):250-251
PENNESI M,
TORRE G, DEL SANTO M, SONZOGNI A.
Glomerulonephritis after recombinant hepatitis B
vaccine. Pediatr Infect Dis J. 2002
Feb;21(2):172-3.
Péricardite
BENSAID J, DENIS F.
Péricardite aigüe bénigne après vaccination contre
l'hépatite B. Press. Med.
1993;22:269
CAILLARD JF,
BASTARD C, CZERNIKOW P, LEMARCHAND C, PROUST B, PRUDENT P.
Effets secondaires de la vaccination contre l’hépatite à
virus B. Etude sur 1047 sujets au CHU de Rouen. Larc
médical. 1985;5:
129-132
PEYRIERE H, HILLAIRE-BUYS D, PONS M, NAVARRE C, DAVY JM, BLAYAC
JP. Acute pericarditis after vaccination against hepatitis B: a
rare effect to be known. Rev. Med. Interne
1997 ;18 :675-676
Pathologie
néo-natale
NIU MT,
SALIVE ME, ELLENBERG SS.
Neonatal death after hepatitis B vaccine. The VAERS
1991-1998.Arch Pediatr Adolesc Med.
1999;153:1279-1282
STAJICH GV, LOPEZ GP, HARRY SW, SEXSON WR. Iatrogenic exposure
to mercury after hepatitis B vaccination in preterm
infants. J.Pediatr.2000
;136(5) : 679-681
AFSSAPS.
Information sur les vaccins Hexavalents : Hexavac® et
InfanrixHexa®
Communiqué de
presse du 9 décembre 2003, accessible en ligne à
: http://www.afssaps.fr/Infos-de-securite/Communiques-de-presse/Information-sur-les-vaccins-Hexavalents-Hexavac-R-et-InfanrixHexa-R
SHAW FE, GRAHAM DJ,
GUESS HA, MILSTIEN JB, JOHNSON JM, SCHATZ GL, HADLER SL,
KURITSKY JN, HINER EE, BREGMAN DJ, MAYNARD JE.
Postmarketing surveillance for neurological adverse
events reported after hepatitis
vaccination. Am. J.
Epidemiol.
1988;127:567-580
DUCLOS P. Adverse events after hepatitis B
vaccination. CMAJ. 1992;147(7):1023-1026
TOSTI ME, TRAVERSA G, BUIANCO E, MELE
A.
Multiple sclerosis
and vaccination against hepatitis B: analysis of risk
benefit profile. Ital J.
Gastroenterol Hepatol.
1999;31(5):388-391
ZIPP F, WEIL JG,
EINHAUPL KM. No increase in demyelinating diseases after
hepatitis B vaccination. Nat Med.
1999;5(9):964-965
SADOVNICK AD, SCHEIFELE
DW.
School-based
hepatitis B vaccination programme and adolescent multiple
sclerosis. Lancet.
2000;355:549-50.
SOUBEYRAND B,
BOISNARD F, BRUEL M, DEBOIS H, DELATTRE D, GAUTHIER A,
SOUM S, THEBAULT C. Central
nervous system demyelinating disease following hepatitis
B vaccination with GenHévac B. Review of ten years of
spontaneous notifications (1989-1998). Presse Med.
2000;29(14):775-780
TOUZE E, GOUT O,
VERDIER-TAILLEFER MH, LYON-CAEN O, ALPEROVITCH A. The
first episode of central nervous system demyelinization
and hepatitis B vaccination. A pilot case-control study.
Rev Neurol. 2000;
156:242-6
STURKENBOOM MCJM, ABENHAIM L, WOLFSON C,
ROULET E, HEINZELF O, GOUT O. Vaccinations, demyelination and
multiple sclerosis study (VDAMS). Pharmacoepidemiol Drug
Safety. 1999;8:S170-1.
ASCHERIO A, ZHANG SM, HERNAN MA,
OLEK MJ, COPLAN PM, BRODOVICZ K,
WALKER AM.
Hepatitis B
vaccination and the risk of multiple
sclerosis. N Engl J Med.
2001 Feb 1;344(5):327-332.
BEGAUD B, ALPEROVITCH
A.
Vaccinations and
multiple sclerosis. N Engl J Med.
2001 ;344(23):1793 (
author reply 1795).
GOUT O.
Vaccinations and
multiple sclerosis. N Engl J Med.
2001;344(23):1794 (author reply
1795)
HOSTETLER L.
Vaccinations and
multiple sclerosis. N Engl J.Med.
2001;344(23) :1795 (author reply
1795)
STURKENBOOM MC, FOURRIER
A.
Vaccinations and
multiple sclerosis. N Engl J Med.
2001 Jun 7;344(23):1794 (author reply
1795)
HANSLIK T, VIBOUD C, FLAHAULT
A.
Vaccinations and
multiple
sclerosis.
N Engl J Med. 2001;344(23):1793-4 (author reply
1795-6)
FOURRIER A,
BEGAUD B, ALPEROVITCH A, VERDIER-TAILLEFER MH, TOUZE E, DECKER
N, IMBS JL Hepatitis B vaccine and first episodes of central
nervous system demyelinating disorders: a comparison between
reported and expected number of cases. British Journal of
Clinical Pharmacology. 2001;51 (5):489
Mc INTYRE CR.
Hepatitis B vaccine: risks and benefits of universal neonatal
vaccinati
on. J Paediatr Child Health.
2001;37(3):215-217
TOUZÉ E,
FOURRIER A, RUE-FENOUCHE C, RONDE-OUSTAU V, JEANTAUD I,
BEGAUD B, ALAPEROVITCH A.
Hepatitis B vaccination and first central nervous system
demyelinating event: a case-control study.
Neuroepidemiology. 2002;
21(4):180-186.
JEFFERSON T, TRAVERSA
G.
Hepatitis B
vaccination: risk-benefit profile and the role of
systematic reviews in the assessment of causality of
adverse events following
immunisation. J Med Virol.
2002;67(3):451-3.
CONFAVREUX C.
Hepatitis B
vaccination and multiple sclerosis: where are
we? Rev Prat.
2002;52(19):2093-5
GEIER MR, GEIER DA.
Hepatitis B vaccination safety. Ann Pharmacother 2002;36:
370-374
GEIER DA, GEIER MR. Chronic adverse reactions
associated with hepatitis B vaccination. Ann Pharmacother
2002;36:1970–1971.
DESTEPHANO F, VERSTRAETEN T, CHEN
RT.
Hepatitis B vaccine
and risk of multiple
sclerosis. Expert Rev
Vaccines. 2002;1(4):461-6.
DESTEPHANO F, VERSTRAETEN T, JACKSON LA, OKORO CA, BENSON P,
BLACK SB, SHINEFIELD HR, MULLOLY JP, LIKOSKY W, CHEN RT;
Vaccine Safety Datalink Research Group, National Immunization
Program, Centers for Disease Control and
Prevention.
Vaccinations and risk of central nervous system demyelinating
diseases in adults. Arch Neurol.
2003;60(4):504-509
DUCLOS P.
Safety of
immunisation and adverse events following vaccination
against hepatitis B. Expert Opin
Drug Saf. 2003 May;2(3):225-31.
IMBS JL, DECKER N,
WELSCH M. Pharmacovigilance of hepatitis B
vaccines. Bull Acad Natl
Med. 2003;187(8):1489-1498; discussion
1498-5000
GEIER MR, GEIER
DA.
A case-series of
adverse events, positive re-challenge of symptoms, and
events in identical twins following hepatitis B
vaccination: analysis of the Vaccine Adverse Event
Reporting System (VAERS) database and literature
review. Clin Exp
Rheumatol. 2004;22(6):749-755
HERNAN MA, JICK SS, OLEK MJ, JICK
H.
Recombinant
hepatitis B vaccine and the risk of multiple sclerosis: a
prospective study. Neurology.
2004 ;63(5):838-842.
McINTYRE CR, KELLY H, JOLLEY D, BUTZKUEVEN H,
SALMON D, HALSEY N, MOULTON LH.
Recombinant
hepatitis B vaccine and the risk of multiple sclerosis: a
prospective study. Neurology.
2005;64(7): 1317 (author reply)
DESTEFANO F,
WEINTRAUB ES, CHEN RT.
Recombinant hepatitis B vaccine and the risk of multiple
sclerosis: a prospective study. Neurology.
2005;64(7):1317 (author reply)
GEIER DA. GEIER
MR
A case-control
study of serious autoimmune adverse events following
hepatitis B
immunization. Autoimmunity.
2005;38(4):295-301.
HERNAN MA, JICK
SS.
Hepatitis B
vaccination and multiple sclerosis: the jury is still
out. Pharmacoepidemiol Drug Saf.
2006;15(9):653-655.
SALLERAS L,
BRUGERA M, PRAT A.
Hepatitis B vaccine and multiple sclerosis: an unproved
association. Med Clin (Barc). 2006 Apr
22;126(15):581-588.
MIKAELOFF Y, CARIDADE G, ASSI S, TARDIEU M, SUISSA S; KIDSEP
study group of the French Neuropaediatric
Society.
Hepatitis B vaccine and risk of relapse after a first childhood
episode of CNS inflammatory
demyelination.
Brain. 2007;130(Pt
4):1105-1110
HOCINE
MN
, FARRINGTON CP, TOUZE E, WHITAKER HJ, FOURRIER A, MOREAU T,
TUBER-BITTER P.
Hepatitis B vaccination and first central nervous system
demyelinating events: reanalysis of a case-control study using
the self-controlled case series method.
Vaccine. 2007;25(31):5938-43.
MIKAELOFF Y,
CARIDADE G, ROSSIER M, SUISSA S, TARDIEU
M.
Hepatitis B
vaccination and the risk of childhood-onset multiple
sclerosis.Arch
Pediatr Adolesc Med.
2007;161(12):1176-1182
MIKAELOFF Y,
CARIDADE G, SUISSA S, TARDIEU
M.
Hepatitis B vaccine
and the risk of CNS inflammatory demyelination in
childhood.Neurology.
2008 Oct 8. [Epub ahead of print]
COSTAGLIOLA D.
Central nervous system demyelinating events and hepatitis B
vaccine: a new episode of the never ending French
saga! Rev Epidemiol
Sante Publique. 2008;56(6):379-381.
ÉTUDES
PHYSIO-PATHOLOGIQUES et REVUES
GÉNÉRALES
CARMELY Y,
DE-MEDINA T. Serious hepatitis B vaccine adverse reaction
are they immune-mediated? Vaccine
1993;11(13):1358-1359
GROTTO I, MANDEL Y,
EPHROS M, ASHKENAZI I, SHEMER J. Major adverse reactions
to yeast-derived hepatitis B vaccines-a review. Vaccine.
1998;16(4):329-334
CAMPINS MARTI M,
MORAGA LLOP FA. Hepatitis B
vaccine and multiple sclerosis An Esp Pediatr.
1998;49(6):555-557.
DIEGO NUNEZ MA, GONZALEZ MENENDEZ AE.
Vaccination against hepatitis B and multiple sclerosis. An Esp
Pediatr. 1999;50(1):97
HALL A, KANE M, ROURE C, MEHEUS A.
Multiple sclerosis and hepatitis B
vaccine?
Vaccine. 1999;17(20-21):2473-2475
CARMELY Y, OREN R.
Hepatitis B side-effet. Lancet
1993;341(8839):250-251
SHOENFELD Y, ARON-MAOR A.
Vaccination and autoimmunity-“vaccinosis”: a dangerous
liaison?
J. Autoimmun.
2000;14(1):1-10.
MONTEYNE P, ANDRE
FE.
Is there a causal
link between hepatitis B vaccination and multiple
sclerosis? Vaccine.
2000;18(19):1994-2001.
JEFFERSON T, HEIJBEL
H
Demyelinating
disease and hepatitis B vaccination: is there a
link? Drug Saf.
2001;24(4):249-254.
CHEN RT, PLESS R, DESTEFANO
F.
Epidemiology of
autoimmune reactions induced by
vaccination. J Autoimmun.
2001;16(3):309-18.
ARON E.
Hepatitis B vaccination. Advocating for a protection principle.
Bull Acad Natl Med. 2002;186(2):361-6; discussion 366-8.
CONFAVREUX C.
Hepatitis B vaccination and multiple sclerosis: where are
we?
Rev Prat.
2002;52(19):2093-5.
PIYASIRISILP S, HEMACHUDHA T.
Neurological adverse events associated with
vaccination.
Curr Opin Neurol. 2002;15(3):333-8
RUTSCHMANN OT, Mc CRORY DC, MATCHAR DB.
Immunization Panel of the Multiple Sclerosis Council for
Clinical Practice Guidelines;
Immunization and
MS: a summary of published evidence and
recommendations. Neurology.
2002;59(12): 837-883.
JEFFERSON T,
TRAVERSA G.
Hepatitis B vaccination: risk-benefit profile and the role of
systematic reviews in the assessment of causality of adverse
events following immunisation. J Med Virol.
2002;67(3):451-3.
GOUT
O.
Vaccinations and multiple sclerosis. Neurol Sci.
2001;22(2):151-154
DEMICHELI V,
RIVETTI A, DI PIETRANTONI C, CLEMENTS CJ, JEFFERSON
T.
Hepatitis B vaccination and multiple sclerosis: evidence from a
systematic review. J Viral Hepat.
2003;10(5):343-4.
DUCLOS P.
Safety of immunisation and adverse events following vaccination
against hepatitis B. Expert Opin Drug Saf.
2003;2(3):225-31
GOUT O, LYON-CAEN
O.
Current opinion
2004: The relationship between multiple sclerosis and
hepatitis B vaccination in
adults. Rev Neurol
(Paris) 2004; 160(12): 1147-1149
VIAL T, DESCOTTES
J. Autoimmune diseases and vaccinations. Eur J Dermatol.
2004;14:86-90
PIAGGIO E, BEN YOUNES A, DESBOIS S, GOUT O,
TOURBAH A, LYON-CAEN O, LIBLAU
RS.
Hepatitis B
vaccination and central nervous system demyelination: an
immunological
approach. J Autoimmun.
2005 Feb;24(1):33-37..
FAURE E.
Multiple sclerosis
and hepatitis B vaccination: could minute contamination
of the vaccine by partial hepatitis B virus polymerase
play a role through molecular
mimicry? Med
Hypotheses. 2005;65(3):509-520
GIRARD M.
Autoimmune hazards
of hepatitis B
vaccine. Autoimmun
Rev. 2005; 4(2):96-100
GIRARD M. Vaccines
in the 21st century : the genetic response and
the innocent bystander. Autoimmun rev. 2005;4 :
79-81
COMENGE Y, GIRARD
M.
Multiple sclerosis
and hepatitis B vaccination: adding the credibility of
molecular biology to an unusual level of clinical and
epidemiological
evidence. Med
Hypotheses. 2006;66(1):84-86.
BOGDANOS DP,
SMITH H, MA Y, BAUM H, MIELI-VERGANI G, VERGANI
D.
A study of molecular mimicry and immunological cross-reactivity
between hepatitis B surface antigen and myelin
mimics. Clin Dev Immunol. 2005
Sep;12(3):217-224
SCHATTNER A.
Consequence or coincidence? The occurrence, pathogenesis
and significance of autoimmune manifestations after viral
vaccines. Vaccine 2005, 23:
3876-3886.
OZAKBAS S, IDIMAN E, YULUG B, PAKOZ B, BAHAR H, GULAY
Z.
Development of multiple sclerosis after vaccination against
hepatitis B: a study based on human leukocyte antigen
haplotypes. Tissue Antigens. 2006
Sep;68(3):235-238
WAISBREN BA
Sr. Acquired autoimmunity
after viral vaccination is caused by molecular mimicry
and antigen complimentarity in the presence of an
immunologic adjuvant and specific HLA
patterns.
Med
Hypotheses. 2008;70(2):346-8.
THESES SUR LES
EFFETS INDESIRABLES DE LA VACCINATION
ANTI-HB
GRÉZARD Pierre : ACCIDENTS DE LA
VACCINATION CONTRE L’HEPATITE B : A PROPOS DE 9 CAS
OBSERVES DE DEBUT 1994 A FIN 1995 - Année 1996 – Université
Claude Bernard LYON I
GRANGE-BLANCHE
SOBOTA
Christophe :
EFFETS INDESIRABLES DES VACCINS RECOMBINANTS CONTRE
L'HÉ
PATITE B. Année 1997 - N° 97/121 - Université
d’AMIENS
RIDONY Catherine
:
EFFETS SECONDAIRES DU VACCIN CONTRE L'H
É
PATITE B
: A PROPOS DE QUATRE CAS - Année 1997 - thèse n° 97/AIX2/0079.
Université d’ AIX
MARSEILLE 2
RÉGNIER Jérôme
:
AFFECTIONS DÉ
MYÉ LINISANTES
CENTRALES ET VACCINATION CONTRE L'HÉPATITE B
DANS LE NORD PAS DE CALAIS : A PROPOS DE 25
CAS
- Année 1998 - Université LILLE 2
DUBERTRET Catherine :
QUATRE CAS DE LYMPHOCYTOME CUTANE BENIN APRES VACCINATION PAR
L'HEPATITE B.
Année 1998. Thèse n° 1092/1998. Université de PARIS 6, PITIE SALPETRIERE.
BOUGNIOT
Catherine
:
ENCEPHALOMYELITES POST VACCINALES APRES VACCINATION CONTRE
L'HEPATITE B : A PROPOS DE 8 OBSERVATIONS
.
Année 1998.Thèse N° 2038. Université PARIS 7,
LARIBOISIERE.
FIQUET Elsa :
LE VACCIN CONTRE L’HÉ
PATITE B EN FRANCE : POLÉMIQUE
AUTOUR DES ASPECTS MÉDICAUX,
SCIENTIFIQUES, JURIDIQUES ET MÉDIATIQUES
– Thèse de Doctorat en Pharmacie - 30 mai 2008 – Université
Claude Bernard LYON I –Thèse
accessible
et téléchargeable sur Internet à l’adresse :
http://jchampavere.free.fr/hepatite_b/
|